Related Experiment Video

Updated: Jan 4, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.3K

The Killer Pseudokinase Mixed Lineage Kinase Domain-Like Protein (MLKL)

James M Murphy1,2

  • 1Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.

Cold Spring Harbor Perspectives in Biology
|November 13, 2019
PubMed

Insights

Necroptosis, a form of programmed cell death, differs from apoptosis by causing cell lysis and immune responses. Its dysregulation is linked to human pathologies, with mixed lineage kinase domain-like protein (MLKL) as a key effector.

Area of Science:

  • Cellular Biology
  • Immunology
  • Molecular Mechanisms of Cell Death

Background:

  • Apoptosis is an immunologically silent cell death pathway.
  • Necroptosis, a lytic cell death pathway, elicits an immune response and is implicated in human pathologies.
  • The pseudokinase mixed lineage kinase domain-like protein (MLKL) is the terminal effector in necroptosis.

Purpose of the Study:

  • To review the current understanding of necroptosis.
  • To elucidate the activation of MLKL by receptor-interacting protein kinase 3 (RIPK3).
  • To discuss the mechanisms of MLKL-mediated cell killing and its regulation.

Main Methods:

  • Review of existing literature on necroptosis.
  • Analysis of molecular pathways involved in MLKL activation and function.
  • Examination of regulatory mechanisms controlling MLKL activity.

Main Results:

  • MLKL is activated by RIPK3, leading to programmed cell death.
  • MLKL mediates cell lysis through proposed mechanisms.
  • Multiple regulatory layers fine-tune MLKL's cell-killing activity.

Conclusions:

  • Necroptosis plays a role in host defense and disease.
  • Understanding MLKL activation and regulation is crucial for therapeutic targeting.
  • Further research into MLKL function can offer insights into treating pathologies associated with necroptosis dysregulation.

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.6K
qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes07:58

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes

Published on: March 6, 2019

9.0K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K